Please Wait
Applying Filters...
menu
    • menu
    Medical Breakthroughs in 2024: Alzheimer’s, schizophrenia, COPD, MASH see pathbreaking treatments

    Data Compilation
    #PharmaFlow

    Pipeline Prospector Oct 2024: Lundbeck acquires Longboard for US$ 2.6 bn; molecular glue degrader tech witnesses dealmaking

    Stock Recap
    #PipelineProspector

    Menu

    Colistimethate Sodium

    ACTIVE PHARMA INGREDIENTS

    DEVELOPMENTS

    FINISHED DOSAGE FORMULATIONS

    DIGITAL CONTENT

    GLOBAL SALES INFORMATION

    MARKET PLACE

    PATENTS & EXCLUSIVITIES

    REF. STANDARDS & IMPURITIES

    PharmaCompass
    $ API Ref.Price (USD/KG) : 3,145Xls download

    Filters

    clear-filterReset all filters
    ListList of Suppliers
    refreshReset Filter
    refresh Reset Filter
    Price Info Price Info
    product-page Product Main Page

    Data in the table can be downloaded after upgrading. In the meantime, you can access the data through the menu.

    Last Updated on PharmaCompass Virtual Booth Country Holder DMF No. Subject Submission Date Status Type GDUFA DMF Review GDUFA Review Date GDUFA Payment Date
    28/10/2024 Hebei Shengxue Dacheng Pharmaceutical Co
    China
    		 HEBEI SHENGXUE DACHENG PHARMACEUTICAL CO LTD 35177 COLISTIMETHATE SODIUM 2020-09-22 Active II Complete 2020-12-29 2020-09-10
    28/10/2024 Livzon Group Fuzhou Fuxing Pharmaceutical Co., Ltd.
    China
    		 LIVZON GROUP FUZHOU FUXING PHARMACEUTICAL CO LTD 28350 COLISTIMETHATE SODIUM 2014-05-30 Active II Complete 2019-09-12 2019-05-16